Compare LULU & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | PEN |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.7B |
| IPO Year | 2007 | 2015 |
| Metric | LULU | PEN |
|---|---|---|
| Price | $102.99 | $319.74 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 37 | 17 |
| Target Price | $104.40 | ★ $362.54 |
| AVG Volume (30 Days) | ★ 3.0M | 355.7K |
| Earning Date | 12-10-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 4.59 | 2.77 |
| Revenue | ★ $11,102,600,000.00 | $1,403,665,000.00 |
| Revenue This Year | N/A | $14.38 |
| Revenue Next Year | N/A | $12.84 |
| P/E Ratio | ★ $22.99 | $115.53 |
| Revenue Growth | 4.86 | ★ 17.50 |
| 52 Week Low | $90.38 | $284.95 |
| 52 Week High | $225.98 | $362.41 |
| Indicator | LULU | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 46.03 |
| Support Level | $95.35 | $315.83 |
| Resistance Level | $104.24 | $320.08 |
| Average True Range (ATR) | 4.39 | 2.17 |
| MACD | -0.72 | -0.24 |
| Stochastic Oscillator | 3.03 | 14.24 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.